Tissue-specific overexpression of SIRT1 was shown to protect mice against age-related disorders such as cardiovascular, neurodegenerative, and metabolic diseases [2, 3], making SIRT1 a prime therapeutic target for such diseases[4-6]. The gene discussed is SIRT1; the disease is Other metabolic disease.